Changing the Conversation on Adult Influenza Vaccination: South Korea
Every year, the Ministry of Health and Welfare in partnership with the Korea Centers for Disease Control and Prevention (KCDC) launches an awareness campaign to promote free vaccination among targeted groups. Timely messages are disseminated through multiple channels, including text messages, the campaign website, formal governmental notices, infographics, videos, posters and press releases.
Excluded from the national influenza immunization program, patients with chronic condition are also largely overlooked from the government-led awareness campaign. To respond to this gap, the Korean Society of Infectious Diseases has committed to driving communication about influenza vaccination to those neglected groups. A series of leaflets produced by the Society describe are targeted to patients with underlying problems with lung, heart, kidney, liver or diabetes about the need for influenza vaccination.
Korean translation of the report and infographic available below.
Campaign Overview: South Korea Report
View the report providing an overview of
the adult influenza campaign in South Korea.
South Korea Resources
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.